17.51USD-3.92%Mkt Cap: 1.19B $P/E: —1d ago
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical ch…
Indicators:|
Key Statistics
Company
Market Cap1.19B $
Enterprise Value3.93B $
Revenue (TTM)2.66B $
Gross Profit1.27B $
Net Income (TTM)-1.13B $
Revenue/Share39.09 USD
Last Price17.51 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS2197981051
Valuation
P/E (Trailing)—
P/E (Forward)7.18
PEG2.06
EV/EBITDA7.99
EV/Revenue1.48
P/S0.45
P/B0.64
EPS (TTM)-17.85
EPS (Forward)2.44
52W Range
9.92030% of range35.58
52W High35.58 USD
52W Low9.920 USD
Profitability
Gross Margin46.67%
Oper. Margin-4.10%
EBITDA Margin18.50%
Profit Margin-41.45%
ROE-58.93%
ROA-19.62%
Growth
Revenue Growth-10.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF105.20M $
CapEx (TTM)188.20M $
FCF Margin7.85%
FCF Yield17.46%
Net Debt2.73B $
Net Debt/EBITDA5.56
Balance Sheet
Debt/Equity1.48
Current Ratio1.43
Quick Ratio0.65
Book Value/Sh27.19 USD
Cash/Share2.059 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)18.63 USD
Upside (mean)+6.3%
Target Range11.00 USD – 38.00 USD
$11.00+6.3% to mean$38.00
# Analysts4
Ownership
Shares Out.68.19M
Float62.11M
Insiders0.89%
Institutions124.10%
Short Interest
Short Ratio6.9d
Short % Float24.75%
Short % Out.18.12%
Shares Short12.35M
Short (prev mo.)11.79M
Technical
SMA 5012.60 (+39.0%)
SMA 20022.17 (-21.0%)
Beta0.76
S&P 52W Chg20.05%
Avg Vol (30d)1.69M
Avg Vol (10d)2.15M
Technical Indicators
RSI (14)66.2
MACD0.6986
MACD Signal0.3079
MACD Hist.+0.3907
BB Upper17.15 USD
BB Middle14.08 USD
BB Lower11.00 USD
BB Width43.71%
ATR (14)1.363 USD
Vol Ratio (20d)0.91x